ELV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Elevance Health, Inc.

Kirby McInerney LLP is investigating potential securities law violations by Elevance Health, Inc. after the Centers for Medicare & Medicaid Services notified the company of intent to impose intermediate sanctions, including suspension of Medicare Advantage enrollment and communication activities due to alleged noncompliance with risk adjustment data submission requirements. The announcement triggered an 8.1% stock price decline on March 2, 2026.

04/22/2026, 8:00 PM • GlobeNewswire

Elevance Health Earnings And Guidance Hike Offset Cost Concerns

Elevance Health reported Q1 2026 adjusted earnings of $12.58 per share, beating consensus of $10.79, with revenues of $49.49 billion up 1.5% YoY. The company raised its 2026 earnings guidance to at least $26.75 per share from $25.50, though margins were pressured by elevated medical costs in Medicaid and a $935 million CMS-related accrual. Stock was up 0.39% at $329.39.

04/22/2026, 3:41 PM • Benzinga

UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments

The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.

04/07/2026, 10:30 AM • Benzinga

Elevance Health, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel is investigating Elevance Health, Inc. following the company's disclosure that the Centers for Medicare & Medicaid Services intends to impose intermediate sanctions, including suspension of enrollment into certain Medicare Advantage-Prescription Drug plans effective March 31, 2026. The law firm is examining whether Elevance and its executives complied with federal securities laws. Investors who suffered losses are encouraged to contact the firm.

03/02/2026, 7:41 PM • GlobeNewswire

Elevance Health Stock Sinks After CMS Freezes Medicare Advantage Enrollment

Elevance Health (ELV) stock declined 7.23% on Monday after the Centers for Medicare & Medicaid Services (CMS) froze the company's Medicare Advantage enrollment effective March 31, 2026. The freeze stems from alleged noncompliance with risk adjustment data submission requirements, including the company's repeated use of USB drives instead of CMS-mandated electronic systems since November 2018. This regulatory action compounds earlier concerns from the company's weak 2026 guidance and CMS's proposed minimal payment increases for Medicare Advantage plans.

03/02/2026, 12:30 PM • Benzinga

Humana Stock Down as Medicare Rate Proposal Hits Insurers

Humana shares plummeted 13.49% in premarket trading following the Trump administration's proposal for nearly flat Medicare Advantage payment rates for 2027, with only a 0.09% net average payment increase versus Wall Street expectations of 4-6%. The broader health insurance sector also suffered significant losses, with CVS Health, UnitedHealth Group, and Elevance Health all declining sharply.

01/27/2026, 7:22 AM • Investing

Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling

The Centers for Medicare & Medicaid Services (CMS) proposed a 2027 Medicare Advantage payment increase of only 0.09%, significantly below Wall Street's expectations of 4-6%. This modest growth announcement triggered sharp declines in major health insurer stocks, with UnitedHealth, Humana, and CVS Health leading the losses. The CMS emphasized program sustainability and payment accuracy through updated risk adjustment models.

01/27/2026, 7:17 AM • Benzinga

UnitedHealth CEO Says Hospitals, Drug Prices Drive US Health Care Costs, Pledges ACA Rebates

UnitedHealth Group CEO Stephen Hemsley testified before House panels that rising hospital prices, consolidation, and prescription drug costs—not insurers—are the primary drivers of U.S. health care spending. He pledged to voluntarily eliminate and rebate profits on ACA exchange coverage this year and urged policy reforms including site-neutral payments and patent reform. UnitedHealth also announced a pilot program to accelerate Medicare Advantage payments for rural hospitals.

01/22/2026, 6:58 AM • Benzinga

3 Beaten-Down Stocks Ready to Kick Off 2026 on the Front Foot

As US stocks start 2026 with positive momentum and the S&P 500 near record highs above 6,900 points, three previously underperforming stocks show signs of recovery. Flowco Holdings is forming a rounding pattern with potential upside to $26, Elevance Health is testing key resistance at $360 with a path to $450, and Matador Resources shows strong fundamentals with a 50% fair value gap and potential recovery above $53.

01/02/2026, 1:32 PM • Investing

3 Beaten-Down Stocks Ready to Kick Off 2026 on the Front Foot

As US stocks reach record highs with the S&P 500 above 6,900 points, three beaten-down stocks show recovery potential in early 2026. Flowco Holdings is forming a rounding pattern with upside toward $26, Elevance Health is testing $360 resistance with a path to $450, and Matador Resources shows strong fundamentals with a 50% fair value gap and potential recovery above $53.

01/02/2026, 11:29 AM • Investing

3 Beaten-Down Stocks Ready to Kick Off 2026 on the Front Foot

The US stock market is positioned for a positive start to 2026 with the S&P 500 targeting the 7,000 point level. Three beaten-down stocks showing recovery potential are highlighted: Flowco Holdings, which is forming a rounding pattern with upside toward $26; Elevance Health, testing resistance at $360 with potential to reach $450; and Matador Resources, supported by strong fundamentals and a 50% fair value gap.

01/02/2026, 10:37 AM • Investing

3 Beaten-Down Stocks Ready to Kick Off 2026 on the Front Foot

The US stock market is positioned for a strong start to 2026 with the S&P 500 near record highs above 6,900 points. Three beaten-down stocks showing recovery potential are highlighted: Flowco Holdings, which is forming a rounding pattern with upside toward $26; Elevance Health, testing resistance at $360 with potential to reach $450; and Matador Resources, supported by strong fundamentals and a 50% fair value gap.

01/02/2026, 4:39 AM • Investing

Why a 63% Vertex Selloff Didn’t Scare Off a New $13 Million Investor

Hyperion Capital Advisors acquired 540,000 shares of Vertex (VERX) worth $13.39 million in Q3, making it the fund's third-largest holding. Despite a 63% stock decline over the past year, the investment signals confidence in Vertex's underlying business fundamentals, including 12.7% revenue growth, 30% cloud revenue growth, and strong cash generation with a $150 million share buyback authorization.

12/24/2025, 1:19 PM • The Motley Fool

White House Set To Unveil Framework To Extend Obamacare Subsidies

The White House is preparing to introduce a healthcare framework to extend Affordable Care Act subsidies, proposing a two-year extension with updated eligibility limits and measures to control premium increases affecting approximately 22 million Americans.

11/24/2025, 10:44 AM • Benzinga

Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings

With market volatility increasing, the article highlights three dividend-paying stocks that reported strong Q3 earnings: Travelers Companies, Elevance Health, and Church & Dwight. These stocks offer potential stability and consistent income amid uncertain market conditions.

11/07/2025, 9:33 AM • Investing